LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement

by | Jul 29, 2026 | Clinical Trials | 0 comments

​ Conditions: Peripheral Arterial Disease

Interventions: Device: LineMatrix® Biological Vascular Graft

Sponsors: Shanghai Zhongshan Hospital

Not yet recruiting Conditions: Peripheral Arterial Disease
Interventions: Device: LineMatrix® Biological Vascular Graft
Sponsors: Shanghai Zhongshan Hospital
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *